NT5E expression and the immune landscape of prostate cancer (PC): An analysis from The Cancer Genome Atlas database.
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2019.37.15_suppl.e16591
Abstract: e16591 Background: Immune checkpoint inhibitors targeting PD-1/L1 and CTLA-4 pathway have shown modest activity in patients with advanced PC. Additional immunosuppressive mechanisms in the PC tumor microenvironment need to be investigated. Increased CD73 (encoded by… read more here.
Keywords: expression; expression immune; nt5e expression; cancer ... See more keywords
Tumor-expressing PD-L1 regulates NT5E expression through MAPK/ERK pathway in triple-negative breast cancer
Sign Up to like & getrecommendations! Published in 2025 at "Oncology Research"
DOI: 10.32604/or.2025.061637
Abstract: Objectives While programmed cell death 1 (PD-1) inhibitors have improved cancer treatment, the function and mechanisms of programmed cell death ligand 1 (PD-L1), particularly when expressed by cancer cells, remain unclear. This study aims to… read more here.
Keywords: nt5e expression; cancer; cancer cells; breast cancer ... See more keywords